Sinopharm Group Co. Ltd. (1099.HK)
HKD 21.45
(-1.15%)
HKD 21.45
(-1.15%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 596.56 Billion | 552.14 Billion | 521.05 Billion | 456.41 Billion | 425.27 Billion | 344.52 Billion |
| Cost of Revenue | 548.05 Billion | 504.71 Billion | 477 Billion | 416.09 Billion | 387.74 Billion | 313.29 Billion |
| Gross Profit | 48.51 Billion | 47.43 Billion | 44.05 Billion | 40.32 Billion | 37.53 Billion | 31.22 Billion |
| Operating Expenses | 26.23 Billion | 24.22 Billion | 22.6 Billion | 20.53 Billion | 19.02 Billion | 15.47 Billion |
| Selling, General and Administrative Expenses | 26.14 Billion | 24.9 Billion | 23.19 Billion | 21.19 Billion | 19.46 Billion | 15.88 Billion |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 2.15 Billion | -676.16 Million | -589.19 Million | -652 Million | -441.16 Million | -413.76 Million |
| Cost and Expenses | 574.29 Billion | 528.94 Billion | 499.6 Billion | 436.63 Billion | 406.76 Billion | 328.77 Billion |
| Operating Income | 22.31 Billion | 20.6 Billion | 19.71 Billion | 17.75 Billion | 16.13 Billion | 15.39 Billion |
| Interest Expense | 2.95 Billion | 3.52 Billion | 3.75 Billion | 3.42 Billion | 3.44 Billion | 4.15 Billion |
| Income Tax Expense | 4.5 Billion | 4.21 Billion | 3.93 Billion | 3.5 Billion | 3.13 Billion | 2.8 Billion |
| Earnings before Tax | 19.51 Billion | 18.56 Billion | 17 Billion | 15.59 Billion | 13.75 Billion | 12.2 Billion |
| Net Income | 9.05 Billion | 14.34 Billion | 13.06 Billion | 12.09 Billion | 10.62 Billion | 9.4 Billion |
| Earnings Per Share Basic | 2.90 | 4.60 | 4.20 | 3.89 | 3.58 | 3.17 |
| Earnings Per Share Diluted | 2.90 | 4.60 | 4.20 | 3.89 | 3.57 | 3.16 |
| Weighted Average Shares Outstanding | 3.11 Billion | 3.12 Billion | 3.11 Billion | 3.11 Billion | 2.96 Billion | 2.96 Billion |
| Weighted Average Shares Outstanding (Diluted) | 3.11 Billion | 3.12 Billion | 3.11 Billion | 3.11 Billion | 2.97 Billion | 2.97 Billion |
| Gross Margin | 0.08 | 0.09 | 0.08 | 0.09 | 0.09 | 0.09 |
| EBIT Margin | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
| Profit Margin | 0.02 | 0.03 | 0.03 | 0.03 | 0.02 | 0.03 |
| EBITDA | 26.89 Billion | 26.24 Billion | 24.68 Billion | 22.61 Billion | 20.31 Billion | 16.67 Billion |
| Earnings Before Tax Margin | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | - | 295.61 Billion | 596.56 Billion | 144.96 Billion | 300.95 Billion | 145.76 Billion |
| Cost of Revenue | - | 270.37 Billion | 548.05 Billion | - | 277.67 Billion | 264.89 Billion |
| Gross Profit | - | 25.24 Billion | 48.51 Billion | 144.96 Billion | 23.27 Billion | -119.13 Billion |
| Operating Expenses | - | 13.73 Billion | 26.23 Billion | 417.63 Billion | 13.09 Billion | -366.01 Billion |
| Selling, General and Administrative Expenses | - | 13.08 Billion | - | 5.72 Billion | 13.68 Billion | 7.8 Billion |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | -41.8 Million | 9.35 Million | - | 28.3 Million |
| Cost and Expenses | - | 284.11 Billion | 574.29 Billion | 139.95 Billion | 290.77 Billion | 138.7 Billion |
| Operating Income | - | 12.48 Billion | 20.2 Billion | 3.46 Billion | 9.83 Billion | 8.01 Billion |
| Interest Expense | - | - | 2.95 Billion | 366.98 Million | - | 1.26 Billion |
| Income Tax Expense | - | 2.52 Billion | 4.5 Billion | 987.09 Million | 1.97 Billion | 1.44 Billion |
| Earnings before Tax | - | 10.64 Billion | 19.51 Billion | 4.16 Billion | 8.86 Billion | 5.97 Billion |
| Net Income | - | 4.94 Billion | 9.05 Billion | 1.99 Billion | 4.1 Billion | 2.66 Billion |
| Earnings Per Share Basic | 0.46 | 1.59 | - | - | 1.32 | 0.85 |
| Earnings Per Share Diluted | 0.46 | 1.59 | - | - | 1.32 | 0.85 |
| Weighted Average Shares Outstanding | 3.08 Billion | 3.11 Billion | 3.12 Billion | - | 3.11 Billion | 3.12 Billion |
| Weighted Average Shares Outstanding (Diluted) | 3.08 Billion | 3.11 Billion | 3.12 Billion | - | 3.11 Billion | 3.13 Billion |
| Gross Margin | - | 0.09 | 0.08 | 1.00 | 0.08 | -0.82 |
| EBIT Margin | - | 0.05 | - | 0.03 | 0.04 | 0.06 |
| Profit Margin | - | 0.02 | 0.02 | 0.01 | 0.01 | 0.02 |
| EBITDA | - | 13.49 Billion | - | 4.3 Billion | 10.9 Billion | 8.49 Billion |
| Earnings Before Tax Margin | - | 0.04 | 0.03 | 0.02 | 0.03 | 0.05 |
MCLL
KYLO
RI
688313
UAHC
MODG